blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1859787

EP1859787 - Sprinkling method for producing powder formulations [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  23.07.2010
Database last updated on 24.08.2024
Most recent event   Tooltip23.07.2010Application deemed to be withdrawnpublished on 25.08.2010  [2010/34]
Applicant(s)For all designated states
Boehringer Ingelheim Pharma GmbH & Co. KG
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2007/48]
Inventor(s)01 / Walz, Michael, Dr.
Prizrenstr. 22
55411, BINGEN / DE
02 / Boeck, Georg, Dr.
Ahornweg 48
88471, LAUPHEIM / DE
 [2007/48]
Representative(s)Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH
CD-Patents
Binger Straße 173
55216 Ingelheim am Rhein / DE
[N/P]
Former [2007/48]Hammann, Heinz, et al
Boehringer Ingelheim Pharma GmbH, CD-Patents, Binger Strasse 173
55216 Ingelheim am Rhein / DE
Application number, filing date07116314.103.08.2002
[2007/48]
Priority number, dateDE200114137723.08.2001         Original published format: DE 10141377
[2007/48]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report 
No.:EP1859787
Date:28.11.2007
Language:DE
[2007/48]
Type: A3 Search report 
No.:EP1859787
Date:14.01.2009
[2009/03]
Search report(s)(Supplementary) European search report - dispatched on:EP17.12.2008
ClassificationIPC:A61K9/00, A61K9/14
[2009/03]
CPC:
A61K9/0075 (EP,US); A61P11/00 (EP); A61P43/00 (EP);
A61K9/1694 (EP,US)
Former IPC [2007/48]A61K9/14
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SK,   TR [2007/48]
TitleGerman:Aufstreuverfahren zur Herstellung von Pulverformulierungen[2007/48]
English:Sprinkling method for producing powder formulations[2007/48]
French:Procédé de saupoudrage pour la production de formulations en poudre[2007/48]
Examination procedure14.07.2009Examination requested  [2009/34]
22.09.2009Despatch of a communication from the examining division (Time limit: M04)
03.02.2010Application deemed to be withdrawn, date of legal effect  [2010/34]
11.03.2010Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2010/34]
Parent application(s)   TooltipEP02754974.0  / EP1429722
Fees paidRenewal fee
14.01.2008Renewal fee patent year 03
14.01.2008Renewal fee patent year 04
14.01.2008Renewal fee patent year 05
14.01.2008Renewal fee patent year 06
01.09.2008Renewal fee patent year 07
31.08.2009Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]FR8142M  (FISONS PHARMACEUTICALS LIMETED, UK) [X] 1-11 * page 1, line 33 - line 40 * * page 3, line 36 - line 42 * * page 4 - page 7; example - * * table 1 * * claim 1 *;
 [X]US5478578  (ARNOLD KLAUS [DE], et al) [X] 1-11 * column 1, line 14 - line 27 * * column 2, line 5 - line 22 * * column 2, line 30 - line 43 * * example - * * claim - *;
 [X]WO9602231  (ASTA MEDICA AG [DE], et al) [X] 1-11 * page 1, line 1 - line 21 * * page 4, line 1 - line 8 * * page 5, line 1 - page 6, line 6 * * page 6, line 27 - line 34 * * page 7, line 8 - line 26 * * page 9 - page 11 * * page 12 - page 14; example - * * claim - *;
 [A]US6221390  (AHMED SALAH U [US], et al) [A] 1-11 * column 2, line 36 - line 44 ** column 4 - column 6; example - *;
 [PX]WO0230389  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [PX] 11 * page 1, line 1 - line 7 * * page 3, line 5 - line 24 * * page 6, line 25 - line 30 * * page 8, line 18 - page 12, line 9 * * page 12 - page 14; example - *;
 [PX]WO0230390  (BOEHRINGER INGELHEIM PHARMA [DE], et al) [PX] 11 * page 1, line 1 - page 3, line 23 * * page 5, line 23 - page 8, line 10 * * examples 1-4 * * claims 1-9 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.